180 Life Sciences Corp. (NASDAQ:ATNF) has a beta value of 0.65 and has seen 4.49 million shares traded in the recent trading session. The company, currently valued at $6.28M, closed the recent trade at $3.53 per share which meant it gained $0.36 on the day or 11.39% during that session. The ATNF stock price is -1922.66% off its 52-week high price of $71.40 and 66.57% above the 52-week low of $1.18. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.73 million shares traded. The 3-month trading volume is 3.85 million shares.
The consensus among analysts is that 180 Life Sciences Corp. (ATNF) is a Buy stock at the moment, with a recommendation rating of 2.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is $0.01.
180 Life Sciences Corp. (NASDAQ:ATNF) trade information
Sporting 11.39% in the green today, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 01/24/23 when the ATNF stock price touched $3.53 or saw a rise of 10.63%. Year-to-date, 180 Life Sciences Corp. shares have moved -6.49%, while the 5-day performance has seen it change -14.78%. Over the past 30 days, the shares of 180 Life Sciences Corp. (NASDAQ:ATNF) have changed 50.24%. Short interest in the company has seen 1.02 million shares shorted with days to cover at 3.72.
Wall Street analysts have a consensus price target for the stock at $4.00, which means that the shares’ value could jump 11.75% from the levels at last check today. The projected low price target is $4.00 while the price target rests at a high of $4.00. In that case, then, we find that the latest price level in today’s session is -13.31% off the targeted high while a plunge would see the stock gain -13.31% from the levels at last check today.
180 Life Sciences Corp. (ATNF) estimates and forecasts
The company’s shares have lost -86.22% over the past 6 months.
180 Life Sciences Corp. is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
180 Life Sciences Corp. (NASDAQ:ATNF)’s Major holders
Insiders own 32.14% of the company shares, while shares held by institutions stand at 6.56% with a share float percentage of 9.67%. Investors are also buoyed by the number of investors in a company, with 180 Life Sciences Corp. having a total of 31 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 1.08 million shares worth more than $0.92 million. As of Jun 29, 2022, Vanguard Group, Inc. (The) held 3.17% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 0.37 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $0.31 million and represent 1.08% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 29, 2022, the former fund manager holds about 2.20% shares in the company for having 0.75 million shares of worth $0.64 million while later fund manager owns 0.31 million shares of worth $0.26 million as of Jun 29, 2022, which makes it owner of about 0.90% of company’s outstanding stock.